Newark, NJ, May 26, 2022 (GLOBE NEWSWIRE) — As per the report published by Fior Markets, The global transcatheter heart valve replacement market is expected to grow from USD 4.54 billion in 2019 to USD 11.63 billion by 2027, at a CAGR of 12.5% during the forecast period 2020-2027. The Europe region stands as a promising market for transcatheter heart valve replacement and is expected to grow at a significant CAGR during the forecast period thanks to technological advancements in the region. In North America, the U.S.A. leads the market. Cardiovascular diseases are one of the most common illnesses among the American population. In, the Asia-Pacific region, India is expected to grow at a high rate due to factors such as growing awareness, increase in healthcare spending, rising elderly population, and an increasing number of heart disease cases.
Get Free Sample Copy: https://www.fiormarkets.com/report-detail/418566/request-sample
Key players in the global transcatheter heart valve replacement market are C Medical Technologies, Neovasc, JC Medical, HighLife Medical, LivaNova, Micro Interventional Devices, Asahi Kasei Group, Edwards Lifesciences Corporation, Meril Life Sciences Pvt. Ltd, Abbott Laboratories, Medtronic plc, and Boston Scientific Corporation among others. Key companies are mainly focusing on developing new products, forming partnerships, and joint ventures to gain significant market share in the global transcatheter heart valve replacement market.
…
